USANA Health Sciences (USNA) Q2 2026: Impairment, Declines, and a Hint of the Omnichannel Pivot

Ticker: USNA. In this quarter, the company reports EPS numbers that underscore a tougher interim, with an earnings surprise leaning to the downside and a revenue forecast that matters for the next laps in its omnichannel journey.

Executive snapshot: earnings, sales, and the non-cash reach of impairment

The second quarter of fiscal 2026 for USANA Health Sciences delivered a clear message from the numbers: net sales of $223 million, down from $236 million a year earlier, i.e., a year-over-year drop of about 5%. The sequential comparison shows a steeper fade of roughly 11%. The headline GAAP result lands in the red: net loss of $21.4 million, highlighted by a substantial, non-cash impairment charge described as preliminary. The impairment figure is nested in the loss calculation, underscoring that this quarter’s challenge isn’t just demand—there’s also a significant accounting write-down at play. Diluted EPS came in at $(1.16), versus $0.52 in the prior year, and adjusted diluted EPS stood at $(0.07) compared with $0.74 a year ago. On the profitability side, Adjusted EBITDA totaled $27.8 million, down from $30.5 million.

Beyond the top-line and the bottom-line, the company also reported softer engagement metrics: Core Nutritional Active Customers numbered 384,000, down from 418,000, while Hiya Active Monthly Subscribers were 166,000 versus 200,400 in the prior year period. In short, the mix shift and the activity base are sending a consistent signal about near-term demand dynamics as USANA presses forward with its evolution toward a diversified, omnichannel business.

Understanding the profit structure: impairment, GAAP vs. non-GAAP, and what it means

The standout line item is the impairment-related hit. The press release notes a “preliminary non-cash impairment charge,” quantified within the quarter’s net loss. This is a reminder that earnings reporting in health and wellness disciplines often carries a non-cash drag that isn’t directly tied to day-to-day operating cash flow, yet it can color readers’ view of ongoing performance. The GAAP EPS of $(1.16) reflects this drag, while the adjusted metric of $(0.07) shows the strip-down to ongoing performance drivers. Investors should parse the gap between GAAP and non-GAAP results to separate the noise from the operating cadence—the latter likely to be the thing management must prove out in the months ahead.

From a business-model lens, the impairment charge highlights the potential misalignment between asset values and the current trajectory of revenue generation. In sectors where product cycles, brand investments, and DTC distribution weigh heavily on asset bases, such charges can foreshadow strategic refocusing—whether by portfolio pruning, reallocation of marketing spend, or acceleration of digital-enabled channels.

Customer base and channel dynamics: a shrinking core, a growing digital footprint?

The sequential and year-over-year declines in active customers and subscribers are noteworthy: Core Nutritional Active Customers slipped to 384,000 (from 418,000), and Hiya Active Monthly Subscribers declined to 166,000 (from 200,400). If you view these numbers through the lens of revenue forecast risk, they imply a softer demand environment for the core product lines and a slower-than-expected monetization of subscription-based channels.

USANA has been signaling an evolution toward a diversified, omnichannel health and wellness platform. The quarter’s numbers suggest this transition is on a path with headwinds rather than a clean acceleration—twisting the story from “new channels, higher lifetime value” to “new channels, tougher user acquisition and retention.” Sector peers facing similar DTC and subscription considerations may watch USANA’s next moves on customer acquisition costs, retention investments, and how it times any margin relief against growth investments.

Outlook and implications for USNA and its peers

USANA notes that it updated its fiscal 2026 guidance. In practice, this means analysts and investors will be recalibrating expectations for the revenue trajectory, the pace of EBITDA recovery, and the pace at which the company can translate customer or subscriber momentum into meaningful margin expansion. The interplay between impairment charges, ongoing operating costs, and any uplift from product mix or channel optimization will be critical to watch in the next few quarters.

For sector peers in the wellness and nutrition space, the quarter illustrates a familiar tension: high growth shifts in consumer health are real, but the financing backdrop and consumer spending volatility can turn that growth into a bumpy ride. The implication for the broader group is nuanced: firms that monetize through a disciplined mix of DTC, retail partnerships, and subscription services—while maintaining cost discipline and transparent capital allocation—will be the ones to outperform in environments where demand signals and asset impairment risk compete for management attention.

Analyst’s lens: what this could portend for earnings dynamics and market psychology

EPS versus earnings expectations remains a focal point for investors who track the pace of profitability in health and wellness names. The divergence between GAAP EPS and adjusted EPS underscores the importance of earnings quality in such disclosures. An earnings surprise to the downside—relative to EPS consensus—could compress near-term multiple multiples until management demonstrates a more durable path to cash-based profitability or a clear plan to monetize higher-value channels.

From a market structure perspective, the impairment charge signals an accounting reminder: in areas with rapid portfolio rotation or significant intangible assets, the balance sheet may tell a different story than the income statement’s best-foot-forward narrative. Sector peers will likely be asked about impairment risk in upcoming quarters, the pace of revenue recovery, and the sustainability of adjusted EBITDA margins as consumer demand patterns shift.

Bottom line: what to watch next

Revenue forecast trajectory: Does USANA’s updated guidance imply a renewed path to sustainable top-line growth, or a longer road to meaningful margin expansion?
Profitability discipline: Will adjusted metrics outpace GAAP results as impairment charges recede from the quarterly baseline?
Channel and product mix: Can the omnichannel strategy lift engagement metrics (active customers, subscribers) while preserving or enhancing gross margins?
Peer comparisons: How will other wellness players balance impairment risk, customer retention, and the cost of retooling their channel strategies?